Cullen/Frost Bankers’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.5M | Buy |
7,882
+443
| +6% | +$76.1K | 0.01% | 305 |
|
|
2026
Q1 | $1.26M | Buy |
7,439
+100
| +1% | +$17.1K | 0.01% | 310 |
|
|
2025
Q4 | $1.24M | Buy |
7,339
+1,789
| +32% | +$291K | 0.01% | 324 |
|
|
2025
Q3 | $801K | Sell |
5,550
-22
| -0.4% | -$3K | 0.01% | 354 |
|
|
2025
Q2 | $705K | Hold |
5,572
| – | – | 0.01% | 363 |
|
|
2025
Q1 | $713K | Sell |
5,572
-82
| -1% | -$11.1K | 0.01% | 352 |
|
|
2024
Q4 | $748K | Buy |
5,654
+82
| +1% | +$11.5K | 0.01% | 333 |
|
|
2024
Q3 | $811K | Buy |
5,572
+22
| +0.4% | +$3.18K | 0.01% | 339 |
|
|
2024
Q2 | $762K | Hold |
5,550
| – | – | 0.01% | 322 |
|
|
2024
Q1 | $762K | Hold |
5,550
| – | – | 0.01% | 326 |
|
|
2023
Q4 | $754K | Hold |
5,550
| – | – | 0.01% | 325 |
|
|
2023
Q3 | $679K | Hold |
5,550
| – | – | 0.01% | 335 |
|
|
2023
Q2 | $705K | Buy |
5,550
+5,250
| +1,750% | +$682K | 0.01% | 336 |
|
|
2023
Q1 | $38.7K | Hold |
300
| – | – | ﹤0.01% | 762 |
|
|
2022
Q4 | $39.4K | Sell |
300
-606
| -67% | -$78.3K | ﹤0.01% | 740 |
|
|
2022
Q3 | $106K | Hold |
906
| – | – | ﹤0.01% | 583 |
|
|
2022
Q2 | $107K | Buy |
906
+606
| +202% | +$71.9K | ﹤0.01% | 595 |
|
|
2022
Q1 | $39K | Hold |
300
| – | – | ﹤0.01% | 781 |
|
|
2021
Q4 | $46K | Hold |
300
| – | – | ﹤0.01% | 765 |
|
|
2021
Q3 | $49K | Hold |
300
| – | – | ﹤0.01% | 768 |
|
|
2021
Q2 | $49K | Hold |
300
| – | – | ﹤0.01% | 784 |
|
|
2021
Q1 | $45K | Hold |
300
| – | – | ﹤0.01% | 744 |
|
|
2020
Q4 | $45K | Hold |
300
| – | – | ﹤0.01% | 731 |
|
|
2020
Q3 | $41K | Hold |
300
| – | – | ﹤0.01% | 711 |
|
|
2020
Q2 | $41K | Buy |
+300
| New | +$38.2K | ﹤0.01% | 690 |
|
|
2017
Q4 | – | Sell |
-3,402
| Closed | -$378K | – | 394 |
|
|
2017
Q3 | $378K | Hold |
3,402
| – | – | 0.01% | 306 |
|
|
2017
Q2 | $352K | Hold |
3,402
| – | – | 0.01% | 307 |
|
|
2017
Q1 | $333K | Hold |
3,402
| – | – | 0.01% | 312 |
|
|
2016
Q4 | $301K | Hold |
3,402
| – | – | 0.01% | 322 |
|
|
2016
Q3 | $328K | Hold |
3,402
| – | – | 0.01% | 311 |
|
|
2016
Q2 | $292K | Sell |
3,402
-426
| -11% | -$38.2K | 0.01% | 322 |
|
|
2016
Q1 | $333K | Buy |
+3,828
| New | +$342K | 0.01% | 307 |
|
|
2014
Q2 | – | Sell |
-3,087
| Closed | -$243K | – | 384 |
|
|
2014
Q1 | $243K | Hold |
3,087
| – | – | 0.01% | 346 |
|
|
2013
Q4 | $234K | Hold |
3,087
| – | – | 0.01% | 344 |
|
|
2013
Q3 | $216K | Buy |
+3,087
| New | +$202K | 0.01% | 354 |
|
Other funds holding IBB
WA
AFG
Cullen/Frost Bankers's IBB Position: Q2 2026 in Review
Cullen/Frost Bankers increased its iShares Biotechnology ETF (IBB) stake by 6% in Q2 2026, buying an estimated $76.1K and bringing the position to 7,882 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #305.
Cullen/Frost Bankers first reported a position in IBB in Q3 2013 and has held it in 35 quarters since. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Cullen/Frost Bankers held 7,882 shares of iShares Biotechnology ETF worth $1.5M as of Q2 2026.
- Cullen/Frost Bankers bought 443 iShares Biotechnology ETF shares in Q2 2026, an estimated $76.1K.
- iShares Biotechnology ETF made up 0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #305 holding.
- Cullen/Frost Bankers first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 35 quarters since.
- 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.